On the other hand, it activated anti-immunogenic responses by reprogramming tumor-associated macrophages from the protumorigenic M2 phenotype to the anti-tumor M1 phenotype, increasing the cytolytic activity of CD8+ T lymphocytes as well, while reducing the proportion of Treg cells [107]. The gene discussed is CD8A; the disease is neoplasm.